Matches in Nanopublications for { ?s ?p "[Therapeutic inhibitors of HER3 should be considered as part of multidrug combinations aimed at completely and rapidly disabling the HER2 network in HER2-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP275628.RAUgNT2t08YvRtMkDL5mV_T5YYfFpxHzI3GwMA-SFfzAA130_assertion description "[Therapeutic inhibitors of HER3 should be considered as part of multidrug combinations aimed at completely and rapidly disabling the HER2 network in HER2-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275628.RAUgNT2t08YvRtMkDL5mV_T5YYfFpxHzI3GwMA-SFfzAA130_provenance.
- assertion description "[Therapeutic inhibitors of HER3 should be considered as part of multidrug combinations aimed at completely and rapidly disabling the HER2 network in HER2-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therapeutic inhibitors of HER3 should be considered as part of multidrug combinations aimed at completely and rapidly disabling the HER2 network in HER2-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP380620.RAa7j0Tx-VPRdJZZbx6vze3y1bPlmxF7q1GNUA5kvj2X8130_assertion description "[Therapeutic inhibitors of HER3 should be considered as part of multidrug combinations aimed at completely and rapidly disabling the HER2 network in HER2-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380620.RAa7j0Tx-VPRdJZZbx6vze3y1bPlmxF7q1GNUA5kvj2X8130_provenance.
- NP1034586.RAOZTsH2ogJQflCAXUZM6ClYL0L7ukkdf6L21Jb6Yebmo130_assertion description "[Therapeutic inhibitors of HER3 should be considered as part of multidrug combinations aimed at completely and rapidly disabling the HER2 network in HER2-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1034586.RAOZTsH2ogJQflCAXUZM6ClYL0L7ukkdf6L21Jb6Yebmo130_provenance.
- NP1034587.RAGnV3uHiCuIMZ_r0I958nIwXrR-UZhWTLH0GCcANDQGc130_assertion description "[Therapeutic inhibitors of HER3 should be considered as part of multidrug combinations aimed at completely and rapidly disabling the HER2 network in HER2-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1034587.RAGnV3uHiCuIMZ_r0I958nIwXrR-UZhWTLH0GCcANDQGc130_provenance.